ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,912.75
1.63%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Theratechnologies Inc (THTX)

  7. Theratechnologies Inc (THTX) 뉴스

THTX Theratechnologies Inc

1.28
-0.06 (-4.48%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Theratechnologies Inc THTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.06 -4.48% 1.28 07:39:15
개장가 저가 고가 종가 전일 종가
1.31 1.27 1.32 1.28 1.34
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202420:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
16/04/202405:15GLOBETheratechnologies Announces Mailing of Management Proxy..
11/04/202420:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
10/04/202420:30GLOBETheratechnologies Reports Financial Results and Provides..
10/04/202420:15IHMARKETNEWSU.S. Index Futures Show Mixed Trend Ahead of Key Inflation..
09/04/202405:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
06/04/202400:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
03/04/202420:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
28/03/202420:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
22/03/202422:36GLOBETheratechnologies Announces Update on its Preclinical..
22/03/202409:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
21/03/202420:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
01/03/202406:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/03/202406:34GLOBETheratechnologies Announces the Resignation of One of Its..
27/02/202422:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/02/202421:30GLOBETheratechnologies Receives Refusal to File Letter for..
21/02/202422:01EDGAR2Form 20-F - Annual and transition report of foreign private..
21/02/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/02/202421:30GLOBETheratechnologies Reports Financial Results for the Fourth..
20/02/202421:30GLOBETheratechnologies Announces Publication in Frontiers in..
15/02/202422:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/02/202421:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
07/02/202404:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/02/202421:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
02/02/202401:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/01/202403:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/01/202421:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
24/01/202404:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/01/202421:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
04/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
03/01/202406:28EDGAR2Form F-3/A - Registration statement by foreign private..
02/01/202423:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
02/01/202421:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
22/12/202306:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/12/202306:12PRNCATheratechnologies annonce le renouvellement de son..
22/12/202306:09PRNCATheratechnologies Announces Renewal of Shelf Prospectus and..
22/12/202303:21EDGAR2Form F-3 - Registration statement by foreign private issuers
14/12/202304:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202321:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
29/11/202306:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
24/11/202321:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
07/11/202303:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202302:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/11/202303:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202301:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202301:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
27/10/202310:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202322:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202321:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
26/10/202305:13GLOBETheratechnologies Announces Proposed Public Offering of..

최근 히스토리

NASDAQ
THTX
Theratechnologies
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유